Zhongsheng pharma director completes share reduction plan

Guangdong Zhongsheng Pharmaceutical announced that its director, vice general manager, and cfo, Ms. Long Chunhua, has completed her share reduction plan. From September 8, 2025, to November 14, 2025, Ms. Long sold 745,900 shares through centralized bidding, representing 0.09% of the company's total share capital. The shares were sold at an average price of CNY 22.34 per share, with prices ranging from CNY 19.18 to CNY 26.00 per share.

The shares originated from Ms. Long's holdings prior to the company's initial public offering and restricted shares granted by the company, including those accrued from capital reserve transfers post-initial public offering. Following this reduction, Ms. Long's total holdings decreased from 0.42% to 0.34% of the total share capital, with her unrestricted shares reducing from 0.11% to 0.02%.

The company confirmed that the share reduction complied with relevant laws, regulations, and exchange rules, and was consistent with Ms. Long's previously disclosed intentions. Ms. Long is not a controlling shareholder, and the implementation of this plan will not lead to a change in the company's control or negatively impact its governance structure and future operations.